Yue-Shan Li (Yueshan Li)

Publication Activity (10 Years)

Years Active: 2021-2024
Publications (10 Years): 11

Top Topics

Inflammatory Response

Top Venues

Journal of medicinal chemistry

ACS applied materials & interfaces

Science (New York, N.Y.)

Nature communications

This page only lists publications with an associated author ORCID identifier.

Publications

Yingying Guo, Yue-Shan Li, Yu Chen, Ahmad Ali, Shun Yao
A New Capillary-Channel Agarose Sponge Assembled with Deep Eutectic Solvent Based Magnetic Fluid for Rapid Hemostasis and Prevention of Bacterial Infection. ACS applied materials & interfaces 16 (24) (2024)
Yingying Guo, Yue-Shan Li, Yu Chen, Ahmad Ali, Shun Yao
A New Capillary-Channel Agarose Sponge Assembled with Deep Eutectic Solvent Based Magnetic Fluid for Rapid Hemostasis and Prevention of Bacterial Infection. ACS applied materials & interfaces (2024)
Liting Zhang, Yue-Shan Li, Chenyu Tian, Ruicheng Yang, Yifei Wang, Haixing Xu, Qiucheng Zhu, Shasha Chen, Linli Li, Shengyong Yang
From Hit to Lead: Structure-Based Optimization of Novel Selective Inhibitors of Receptor-Interacting Protein Kinase 1 (RIPK1) for the Treatment of Inflammatory Diseases. Journal of medicinal chemistry 67 (1) (2023)
Liting Zhang, Yue-Shan Li, Chenyu Tian, Ruicheng Yang, Yifei Wang, Haixing Xu, Qiucheng Zhu, Shasha Chen, Linli Li, Shengyong Yang
From Hit to Lead: Structure-Based Optimization of Novel Selective Inhibitors of Receptor-Interacting Protein Kinase 1 (RIPK1) for the Treatment of Inflammatory Diseases. Journal of medicinal chemistry (2023)
Liting Zhang, Yue-Shan Li, Chenyu Tian, Ruicheng Yang, Yifei Wang, Haixing Xu, Qiucheng Zhu, Shasha Chen, Linli Li, Shengyong Yang
From Hit to Lead: Structure-Based Optimization of Novel Selective Inhibitors of Receptor-Interacting Protein Kinase 1 (RIPK1) for the Treatment of Inflammatory Diseases. Journal of medicinal chemistry 67 (1) (2023)
Liting Zhang, Yue-Shan Li, Chenyu Tian, Ruicheng Yang, Yifei Wang, Haixing Xu, Qiucheng Zhu, Shasha Chen, Linli Li, Shengyong Yang
From Hit to Lead: Structure-Based Optimization of Novel Selective Inhibitors of Receptor-Interacting Protein Kinase 1 (RIPK1) for the Treatment of Inflammatory Diseases. Journal of medicinal chemistry 67 (1) (2023)
Yue-Shan Li, Liting Zhang, Yi-Fei Wang, Jun Zou, Ruicheng Yang, Xinling Luo, Chengyong Wu, Wei Yang, Chenyu Tian, Haixing Xu, Falu Wang, Xin Yang, Linli Li, Sheng-Yong Yang
Generative deep learning enables the discovery of a potent and selective RIPK1 inhibitor. Nature communications 13 (1) (2022)
Yue-Shan Li, Liting Zhang, Ruicheng Yang, Zeen Qiao, Ming Wu, Chong Huang, Chenyu Tian, Xinling Luo, Wei Yang, Yun Zhang, Linli Li, Sheng-Yong Yang
Discovery of 3,4-Dihydrobenzo[ f ][1,4]oxazepin-5(2 H )-one Derivatives as a New Class of Selective TNIK Inhibitors and Evaluation of Their Anti-Colorectal Cancer Effects. Journal of medicinal chemistry 65 (3) (2022)
Zichao Luo, Xiuqi Liang, Tao He, Xian Qin, Xinchao Li, Yue-Shan Li, Lu Li, Xian Jun Loh, Changyang Gong, Xiaogang Liu
Lanthanide-Nucleotide Coordination Nanoparticles for STING Activation. Journal of the American Chemical Society 144 (36) (2022)
Jingxin Qiao, Yue-Shan Li, Rui Zeng, Feng-Liang Liu, Rong-Hua Luo, Chong Huang, Yi-Fei Wang, Jie Zhang, Baoxue Quan, Chenjian Shen, Xin Mao, Xinlei Liu, Weining Sun, Wei Yang, Xincheng Ni, Kai Wang, Ling Xu, Zi-Lei Duan, Qing-Cui Zou, Hai-Lin Zhang, Wang Qu, Yang-Hao-Peng Long, Ming-Hua Li, Rui-Cheng Yang, Xiaolong Liu, Jing You, Yangli Zhou, Rui Yao, Wen-Pei Li, Jing-Ming Liu, Pei Chen, Yang Liu, Gui-Feng Lin, Xin Yang, Jun Zou, Linli Li, Yiguo Hu, Guang-Wen Lu, Wei-Min Li, Yu-Quan Wei, Yong-Tang Zheng, Jian Lei, Sheng-Yong Yang
SARS-CoV-2 Mpro inhibitors with antiviral activity in a transgenic mouse model. Science (New York, N.Y.) 371 (6536) (2021)
Lei Zhong, Yue-Shan Li, Liang Xiong, Wenjing Wang, Ming Wu, Ting Yuan, Wei Yang, Chenyu Tian, Zhuang Miao, Tianqi Wang, Shengyong Yang
Small molecules in targeted cancer therapy: advances, challenges, and future perspectives. Signal transduction and targeted therapy 6 (1) (2021)